Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies

被引:40
作者
Fernandez, Elena Fernandez [1 ]
Santos-Carballal, Beatriz [2 ]
de Santi, Chiara [1 ]
Ramsey, Joanne M. [3 ]
MacLoughlin, Ronan [3 ,4 ,5 ]
Cryan, Sally-Ann [3 ]
Greene, Catherine M. [1 ]
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Dept Clin Microbiol, Lung Biol Grp, Dublin 9, Ireland
[2] ChiPro GmbH, Anne Conway Str 1, D-28359 Bremen, Germany
[3] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland
[4] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin 2, Ireland
[5] Aerogen Ltd, Galway Business Pk, Galway H91 HE94, Ireland
来源
MATERIALS | 2018年 / 11卷 / 01期
关键词
cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); lung gene delivery; nanoparticles; biopolymers; PLGA; chitosan; Locked-Nucleic Acid (LNA); TRANSMEMBRANE CONDUCTANCE REGULATOR; DRY POWDER FORMULATIONS; DRUG-DELIVERY; PARTICLE-SIZE; CELL THERAPY; IN-VITRO; CHITOSAN; SYSTEMS; DISEASE; SIRNA;
D O I
10.3390/ma11010122
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Lung gene therapy for cystic fibrosis disease has not been successful due to several challenges such as the absence of an appropriate vector. Therefore, optimal delivery of emerging therapeutics to airway epithelial cells demands suitable non-viral systems. In this work, we describe the formulation and the physicochemical investigation of biocompatible and biodegradable polymeric nanoparticles (NPs), including PLGA and chitosan (animal and non-animal), as novel methods for the safe and efficient delivery of CFTR-specific locked nucleic acids (LNAs).
引用
收藏
页数:15
相关论文
共 56 条
[1]  
Akbuga J., 2016, Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, P337, DOI [10.1007/978-3-662-47862-2_22, DOI 10.1007/978-3-662-47862-2_22]
[2]  
Alton EricW.F.W., 2015, The Lancet Respiratory Medicine
[3]   Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression [J].
Amato, Felice ;
Tomaiuolo, Rossella ;
Nici, Fabrizia ;
Borbone, Nicola ;
Elce, Ausilia ;
Catalanotti, Bruno ;
D'Errico, Stefano ;
Morgillo, Carmine Marco ;
De Rosa, Giuseppe ;
Mayol, Laura ;
Piccialli, Gennaro ;
Oliviero, Giorgia ;
Castaldo, Giuseppe .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[4]   Gene therapy in cystic fibrosis [J].
Armstrong, David K. ;
Cunningham, Steve ;
Davies, Jane C. ;
Alton, Eric W. F. W. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (05) :465-468
[5]  
Bose S., 2012, ACTA BIOMATER
[6]   Role of particle size in phagocytosis of polymeric microspheres [J].
Champion, Julie A. ;
Walker, Amanda ;
Mitragotri, Samir .
PHARMACEUTICAL RESEARCH, 2008, 25 (08) :1815-1821
[7]   Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles [J].
Colombo, Stefano ;
Cun, Dongmei ;
Remaut, Katrien ;
Bunker, Matt ;
Zhang, Jianxin ;
Martin-Bertelsen, Birte ;
Yaghmur, Anan ;
Braeckmans, Kevin ;
Nielsen, Hanne M. ;
Foged, Camilla .
JOURNAL OF CONTROLLED RELEASE, 2015, 201 :22-31
[8]   Gene and cell therapy for cystic fibrosis: From bench to bedside [J].
Conese, Massimo ;
Ascenzioni, Fiorentina ;
Boyd, A. Christopher ;
Coutelle, Charles ;
De Fino, Ida ;
de Smedt, Stefaan ;
Rejman, Joanna ;
Rosenecker, Joseph ;
Schindelhauer, Dirk ;
Scholte, Bob J. .
JOURNAL OF CYSTIC FIBROSIS, 2011, 10 :S114-S128
[9]   High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization [J].
Cun, Dongmei ;
Jensen, Ditte Krohn ;
Maltesen, Morten Jonas ;
Bunker, Matthew ;
Whiteside, Paul ;
Scurr, David ;
Foged, Camilla ;
Nielsen, Hanne Morck .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 77 (01) :26-35
[10]   New perspectives in nanotherapeutics for chronic respiratory diseases [J].
da Silva A.L. ;
Cruz F.F. ;
Rocco P.R.M. ;
Morales M.M. .
Biophysical Reviews, 2017, 9 (5) :793-803